Published 12/29/2017


ZeptoMetrix Corporation has announced that Shawn R. Smith has been named President and Chief Executive Officer effective immediately. As President and CEO, Mr. Smith will have responsibilities for all of the Company's Operations, Research & Development and Sales. He will report directly to the Board of Directors.

As a 25 year veteran of the life science market, Mr. Smith brings with him a wealth of industry knowledge and experience. Building an impressive track record of strategic, operational and commercial accomplishments, Mr. Smith has long established himself to be a confident and trusted leader bringing with him a strong reputation for developing people and inspiring teams. “The Board unanimously agrees that Shawn’s ability to lead, his aptitude for strategic planning and his demonstrated talent to deliver results will prove to be his most valuable assets as we continue to grow and develop new relationships and new product lines,” said James C.D. Hengst, Ph.D., Board of Directors Member.

About ZeptoMetrix®:
ZeptoMetrix Corporation (ZMC) is a renowned industry leader and innovator identified with quality, reliable and trusted products and services for infectious disease diagnostic development. ZeptoMetrix is a fully integrated biotechnology company whose offerings support all phases of research & development, validation, manufacturing and commercialization of diagnostic testing.
Founded in 1999, ZeptoMetrix is headquartered in Buffalo, NY with additional facilities in Franklin, Massachusetts.

Welcome To